Nelfinavir (repurposed for myelofibrosis anemia)
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-02-04 — Treating Anemia in Myelofibrosis With Repurposed Drugs (Nelfinavir) That Restore Iron Delivery to the Bone Marrow: Phase I/II trial investigating nelfinavir, a repurposed HIV protease inhibitor, for myelofibrosis anemia via proposed restoration of iron delivery to bone marrow, with secondary endpoint of reducing serum fibrosis biomarkers (trial-early). (novelty: 4)
Open questions
Related
Contributing findings
Treating Anemia in Myelofibrosis With Repurposed Drugs (Nelfinavir) That Restore Iron Delivery to the Bone Marrow
04-feb-2026
novelty 4
per-area 4
introduces